Conversations about cholesterol seem almost impossible to avoid-especially as we get older. But, according to experts there ...
Very low bad (LDL) cholesterol may increase future risk of diabetes even in people who do not take statins. LDL-C could be a warning sign for metabolic imbalance.
New review shows statins remain first-line therapy in MASLD, while PCSK9 inhibitors offer potential but require more evidence. Learn more about evolving treatment guidance.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback